Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time
JCO Precision Oncology · 2025
DOI: 10.1200/po.24.00299 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2025. Verfasst von Peng Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
PURPOSE A 70-gene liquid biopsy (LB) panel (LBP-70) was implemented at our institution to identify genetic alterations in the plasma of patients with solid tumors. We report the clinical utility of LBP-70 in a retrospective study of 1,243 consecutively tested patients. MATERIALS AND METHODS Electronic medical records were reviewed for relevant clinicopathologic and radiologic information and preanalytical variables, including circulating cell-free DNA yield. The clinical utility of the LBP-70 assay was evaluated on the basis of its ability to identify major tumor drivers and/or targetable alterations and the concordance of the LBP-70 results with tissue genotyping and radiologic findings. RESULTS Positive LB findings were reported in 75% of patients, ranging from 67% to 85% among various tumor types and 60% to 77% in different tumor stages within an average of seven workdays. The mutant allele frequency (AF) ranged from 0.1% to 90%, and 50% of the variants were detected at AF
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
ORCID-Profile: Peng Wang, Richard Kenneth Yang, Fatima Zahra Jelloul, Rajyalakshmi Luthra, Mark J Routbort, Hui Chen, Chi Young Ok, Rashmi Kanagal-Shamanna, Sinchita Roy-Chowdhuri, L Jeffrey Medeiros, Keyur P Patel
Zitieren
APA
Wang, P., Yang, R. K., Jelloul, F. Z., Luthra, R., Routbort, M. J., Chen, H., Loghavi, S., Ok, C. Y., Kanagal-Shamanna, R., Roy-Chowdhuri, S., Medeiros, L. J., & Patel, K. P. (2025). Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time. JCO Precision Oncology. https://doi.org/10.1200/po.24.00299
Vancouver
Wang P, Yang RK, Jelloul FZ, Luthra R, Routbort MJ, Chen H, et al. Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time. JCO Precision Oncology. 2025. doi:10.1200/po.24.00299
BibTeX
@article{Wang2025,
author = {Wang, Peng and Yang, Richard Kenneth and Jelloul, Fatima Zahra and Luthra, Rajyalakshmi and Routbort, Mark J and Chen, Hui and Loghavi, Sanam and Ok, Chi Young and Kanagal-Shamanna, Rashmi and Roy-Chowdhuri, Sinchita and Medeiros, L Jeffrey and Patel, Keyur P},
title = {Routine Clinical Liquid Biopsy Testing for Solid Tumors Delivers the Promise of Minimally Invasive Detection of Genomic Variants With a Faster Turnaround Time},
journal = {JCO Precision Oncology},
year = {2025},
doi = {10.1200/po.24.00299}
}
EUVIMED